{"id":9742,"date":"2026-04-01T10:08:12","date_gmt":"2026-04-01T02:08:12","guid":{"rendered":"https:\/\/regask.com\/?p=9742"},"modified":"2026-04-01T10:08:12","modified_gmt":"2026-04-01T02:08:12","slug":"actualizaciones-de-anvisa-brasil-sobre-cepas-de-vacunas-contra-la-covid-19-medicamentos-de-bajo-riesgo-y-normas-sobre-ingredientes","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","title":{"rendered":"La ANVISA de Brasil actualiza las cepas de la vacuna contra la COVID-19, de bajo riesgo\u2026"},"content":{"rendered":"<p>En <strong>24 de marzo de 2026,<\/strong> el <strong>Agencia Nacional de Vigilancia Sanitaria de Brasil (ANVISA)<\/strong> anunci\u00f3 un conjunto de actualizaciones regulatorias que afectan a<strong> Composici\u00f3n de la vacuna contra la COVID-19, procedimientos de notificaci\u00f3n de medicamentos de bajo riesgo, ingredientes de los suplementos diet\u00e9ticos y restricciones de productos cosm\u00e9ticos.<\/strong> Los cambios se aplican a <strong>fabricantes farmac\u00e9uticos, productores de suplementos diet\u00e9ticos y empresas de cosm\u00e9ticos<\/strong> operando en Brasil.<\/p>\n<div class=\"row\"  id=\"row-1181995389\">\n\n\t<div id=\"col-1479001834\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-912795197\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-912795197 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Detalles de la actualizaci\u00f3n<\/h2>\n\t<div id=\"gap-486143916\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-486143916 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">La actualizaci\u00f3n introduce flexibilidad en\u00a0<\/span><b><span data-contrast=\"auto\">Composici\u00f3n de la vacuna contra la COVID-19<\/span><\/b><span data-contrast=\"auto\">, permitiendo que las vacunas incluyan cualquiera de los dos\u00a0<\/span><b><span data-contrast=\"auto\">LP.8.1<\/span><\/b><span data-contrast=\"auto\">\u00a0o\u00a0<\/span><b><span data-contrast=\"auto\">cepas virales JN.1<\/span><\/b><span data-contrast=\"auto\">, y la selecci\u00f3n final queda a discreci\u00f3n del Ministerio de Salud.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Paralelamente, ANVISA ha ampliado el alcance de\u00a0<\/span><b><span data-contrast=\"auto\">Medicamentos de bajo riesgo que pueden acogerse a una notificaci\u00f3n simplificada antes de su comercializaci\u00f3n.<\/span><\/b><span data-contrast=\"auto\">, ahora incluyendo\u00a0<\/span><b><span data-contrast=\"auto\">povidona yodada, paracetamol, simeticona y subsalicilato de bismuto<\/span><\/b><span data-contrast=\"auto\">, simplificando los procesos de entrada regulatoria para estos productos.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La agencia tambi\u00e9n ha autorizado nuevos\u00a0<\/span><b><span data-contrast=\"auto\">ingredientes de los suplementos diet\u00e9ticos<\/span><\/b><span data-contrast=\"auto\">, incluido\u00a0<\/span><b><span data-contrast=\"auto\">Aceite de nuez de baru<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">aceite de microalgas que contiene DHA (<\/span><\/b><b><i><span data-contrast=\"auto\">Esquizoquitrio<\/span><\/i><\/b><b><span data-contrast=\"auto\">\u00a0esp.)<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">concentrado de a\u00e7a\u00ed liofilizado<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">Bifidobacterium animalis subsp. lactis<\/span><\/b><span data-contrast=\"auto\">, y\u00a0<\/span><b><span data-contrast=\"auto\">Streptococcus salivarius K12<\/span><\/b><span data-contrast=\"auto\">. Estos ingredientes est\u00e1n sujetos a\u00a0<\/span><b><span data-contrast=\"auto\">l\u00edmites de uso definidos y requisitos de etiquetado<\/span><\/b><span data-contrast=\"auto\">, reforzando las obligaciones de cumplimiento.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Adem\u00e1s, ANVISA ha reafirmado la\u00a0<\/span><b><span data-contrast=\"auto\">Prohibici\u00f3n de productos para u\u00f1as que contengan \u00f3xido de difenil(2,4,6-trimetilbenzoil)fosfina (TPO) y N,N-dimetil-p-toluidina (DMPT).<\/span><\/b><span data-contrast=\"auto\">. La restricci\u00f3n se mantiene vigente independientemente de cualquier apelaci\u00f3n pendiente, lo que confirma su estricta aplicaci\u00f3n.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1479001834 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1736052901\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Fecha de entrada en vigor<\/h2>\n\t<div id=\"gap-1943547599\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1943547599 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">Las actualizaciones regulatorias fueron\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">Anunciado el 24 de marzo de 2026.<\/span><\/span><span class=\"TextRun SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">.<\/span><\/span><span class=\"EOP SCXW194959746 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1736052901 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1235652058\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Por qu\u00e9 es importante<\/h2>\n\t<div id=\"gap-519731616\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-519731616 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Estas actualizaciones mejoran<strong> claridad regulatoria<\/strong> definiendo las cepas de vacunas permitidas y los ingredientes autorizados, al tiempo que se apoya<strong> eficiencia digital y procedimental<\/strong> a trav\u00e9s de v\u00edas de notificaci\u00f3n simplificadas para medicamentos de bajo riesgo. Al mismo tiempo, la aplicaci\u00f3n continua de las restricciones cosm\u00e9ticas garantiza <strong>est\u00e1ndares de cumplimiento consistentes<\/strong> con una m\u00ednima carga regulatoria adicional para los productos que cumplen con los requisitos.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1235652058 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-65746949\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>A qui\u00e9n afecta esto<\/h2>\n\t<div id=\"gap-1928929931\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1928929931 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">Esta actualizaci\u00f3n es relevante para<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">equipos de asuntos regulatorios, garant\u00eda de calidad, I+D y cumplimiento normativo<\/span><\/span><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">,<\/span><\/span><\/strong><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\"> as\u00ed como <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">Equipos de TI y transformaci\u00f3n digital<\/span><\/span><\/strong><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">\u00a0Responsable de gestionar los flujos de trabajo regulatorios y los datos de productos en las carteras de productos farmac\u00e9uticos, suplementos y cosm\u00e9ticos.<\/span><\/span><span class=\"EOP SCXW220643823 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-65746949 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1700217482\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pr\u00f3ximos pasos<\/h2>\n\t<div id=\"gap-461977837\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-461977837 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Las empresas deber\u00edan\u00a0<\/span><b><span data-contrast=\"auto\">evaluar las carteras de productos actuales<\/span><\/b><span data-contrast=\"auto\">\u00a0en relaci\u00f3n con los requisitos actualizados, incluidas las opciones de composici\u00f3n de las vacunas, la elegibilidad para la notificaci\u00f3n de medicamentos de bajo riesgo, los ingredientes autorizados de los suplementos diet\u00e9ticos y las restricciones de sustancias cosm\u00e9ticas. Las partes interesadas deben coordinar\u00a0<\/span><b><span data-contrast=\"auto\">revisiones interfuncionales<\/span><\/b><span data-contrast=\"auto\">\u00a0Actualizar los documentos reglamentarios, las pr\u00e1cticas de etiquetado y los controles de la cadena de suministro para garantizar el cumplimiento continuo de las regulaciones de ANVISA.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">A medida que las actualizaciones normativas se vuelven m\u00e1s frecuentes y complejas en m\u00faltiples categor\u00edas de productos, las organizaciones pueden beneficiarse de la inteligencia centralizada y la automatizaci\u00f3n para anticiparse a los cambios.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\">RegASK<\/a>\u00a0es una plataforma l\u00edder de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con inteligencia artificial de agencia.<\/span><\/b><span data-contrast=\"auto\">\u00a0que permite a las organizaciones globales en sectores altamente regulados, como productos de consumo y ciencias de la vida, gestionar de forma proactiva entornos regulatorios complejos. Al combinar la IA Agentic avanzada con expertos en el sector,\u00a0<a href=\"http:\/\/regask.com\/es\/\">RegASK<\/a>\u00a0Ofrece informaci\u00f3n predictiva y pr\u00e1ctica en tiempo real, as\u00ed como automatizaci\u00f3n integral, lo que agiliza los procesos de cumplimiento, mitiga los riesgos y acelera el acceso al mercado en m\u00e1s de 160 pa\u00edses.\u00a0<\/span><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\">M\u00e1s informaci\u00f3n<\/a> o <a href=\"https:\/\/regask.com\/es\/reservar-una-demostracion\/\">Reserve una demostraci\u00f3n ahora.<\/a><\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1700217482 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1821164762\">\n\n\t<div id=\"col-317865736\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>Preguntas frecuentes<\/h3>\n\t<div id=\"gap-1743146835\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1743146835 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW85757934 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85757934 BCX0\">\u00bfCu\u00e1les son las cepas de COVID-19?\u00a0<\/span><span class=\"NormalTextRun SCXW85757934 BCX0\">permitido<\/span><span class=\"NormalTextRun SCXW85757934 BCX0\">\u00a0\u00bfSeg\u00fan las directrices actualizadas de ANVISA?<\/span><\/span><span class=\"EOP SCXW85757934 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1765266253\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1765266253 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\">Las vacunas contra el COVID-19 pueden incluir cualquiera de las siguientes:\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\">Cepas virales LP.8.1 o JN.1<\/span><\/span><\/strong><span class=\"TextRun SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\"><strong>,<\/strong> con final\u00a0<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">selecci\u00f3n<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">determinado<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">\u00a0por el Ministerio de Salud.<\/span><\/span><span class=\"EOP SCXW132553472 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-317865736 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1497087798\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW177685408 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW177685408 BCX0\">\u00bfQu\u00e9 medicamentos cumplen los requisitos para la notificaci\u00f3n simplificada en Brasil?<\/span><\/span><span class=\"EOP SCXW177685408 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1763514195\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1763514195 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><strong><span class=\"TextRun MacChromeBold SCXW62415161 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW62415161 BCX0\">Povidona yodada, paracetamol, simeticona y subsalicilato de bismuto<\/span><\/span><\/strong><span class=\"TextRun SCXW62415161 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW62415161 BCX0\">\u00a0Ahora pueden acogerse a un proceso de notificaci\u00f3n simplificada como medicamentos de bajo riesgo antes de su comercializaci\u00f3n.<\/span><\/span><span class=\"EOP SCXW62415161 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1497087798 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-595379852\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW147526865 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147526865 BCX0\">\u00bfQu\u00e9 nuevos ingredientes est\u00e1n autorizados para los complementos alimenticios?<\/span><\/span><span class=\"EOP SCXW147526865 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-556567220\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-556567220 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Los ingredientes autorizados incluyen:\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Aceite de nuez de baru<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">aceite de microalgas con DHA (<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW152755442 BCX0\">Esquizoquitrio<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">\u00a0esp.)<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">concentrado de a\u00e7a\u00ed liofilizado<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Bifidobacteria\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW152755442 BCX0\">animalis<\/span><span class=\"NormalTextRun SCXW152755442 BCX0\">\u00a0subespecie lactis<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">, y\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Streptococcus salivarius K12<\/span><\/span><\/strong><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\"><strong>,<\/strong> sujeto a l\u00edmites de uso y requisitos de etiquetado.<\/span><\/span><span class=\"EOP SCXW152755442 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-595379852 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-882639590\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW204239453 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW204239453 BCX0\">\u00bfC\u00f3mo puedo?\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW204239453 BCX0\">RegASK<\/span><span class=\"NormalTextRun SCXW204239453 BCX0\">\u00a0\u00bfNecesita ayuda con las actualizaciones de cumplimiento de TITCK?<\/span><\/span><span class=\"EOP SCXW204239453 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1927418202\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1927418202 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW193127493 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW193127493 BCX0\">\u00a0ayuda a las organizaciones\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW193127493 BCX0\">Realice un seguimiento de los cambios regulatorios en tiempo real, eval\u00fae el impacto del producto y optimice los flujos de trabajo de cumplimiento.<\/span><\/span><\/strong><span class=\"TextRun SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW193127493 BCX0\"><strong>,<\/strong> permitiendo una adaptaci\u00f3n m\u00e1s r\u00e1pida a\u00a0<\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW193127493 BCX0\">actualizaciones<\/span><span class=\"NormalTextRun SCXW193127493 BCX0\">\u00a0tales como cambios en la composici\u00f3n de las vacunas, autorizaciones de ingredientes y restricciones de productos en Brasil.<\/span><\/span><span class=\"EOP SCXW193127493 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-882639590 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On March 24, 2026, the Brazilian National Health Surveillance Agency (ANVISA) announced a set of regulatory updates impacting COVID-19 vaccine composition, low-risk medicines notification procedures, dietary supplement ingredients, and cosmetic product restrictions. The changes apply to pharmaceutical manufacturers, dietary supplement producers, and cosmetic companies operating in Brazil.<\/p>","protected":false},"author":41,"featured_media":9743,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[512,33,35],"tags":[],"class_list":["post-9742","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-brazil-regulations","category-news","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Brazil ANVISA Updates COVID-19 Vaccine Strains and Rules<\/title>\n<meta name=\"description\" content=\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/actualizaciones-de-anvisa-brasil-sobre-cepas-de-vacunas-contra-la-covid-19-medicamentos-de-bajo-riesgo-y-normas-sobre-ingredientes\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Risk Medicines, and Ingredient Rules\" \/>\n<meta property=\"og:description\" content=\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/actualizaciones-de-anvisa-brasil-sobre-cepas-de-vacunas-contra-la-covid-19-medicamentos-de-bajo-riesgo-y-normas-sobre-ingredientes\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T02:08:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\"},\"headline\":\"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris&hellip;\",\"datePublished\":\"2026-04-01T02:08:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"},\"wordCount\":749,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"articleSection\":[\"Brazil\",\"Regulatory News\",\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\",\"name\":\"Brazil ANVISA Updates COVID-19 Vaccine Strains and Rules\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"datePublished\":\"2026-04-01T02:08:12+00:00\",\"description\":\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"width\":800,\"height\":600,\"caption\":\"Brazil Anvisa Updates Covid 19 Vaccine Strains Low Risk Medicines And Ingredient Rules\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\",\"name\":\"Shaffa Renaningtyas\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La ANVISA de Brasil actualiza las cepas y normas de la vacuna contra la COVID-19.","description":"Consulta las \u00faltimas actualizaciones de la ANVISA de Brasil sobre las cepas de la vacuna contra la COVID-19 y las nuevas normas para medicamentos e ingredientes de bajo riesgo.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/actualizaciones-de-anvisa-brasil-sobre-cepas-de-vacunas-contra-la-covid-19-medicamentos-de-bajo-riesgo-y-normas-sobre-ingredientes\/","og_locale":"es_ES","og_type":"article","og_title":"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Risk Medicines, and Ingredient Rules","og_description":"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.","og_url":"https:\/\/regask.com\/es\/actualizaciones-de-anvisa-brasil-sobre-cepas-de-vacunas-contra-la-covid-19-medicamentos-de-bajo-riesgo-y-normas-sobre-ingredientes\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-04-01T02:08:12+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#article","isPartOf":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6"},"headline":"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris&hellip;","datePublished":"2026-04-01T02:08:12+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"},"wordCount":749,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","articleSection":["Brazil","Regulatory News","Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","url":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","name":"La ANVISA de Brasil actualiza las cepas y normas de la vacuna contra la COVID-19.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","datePublished":"2026-04-01T02:08:12+00:00","description":"Consulta las \u00faltimas actualizaciones de la ANVISA de Brasil sobre las cepas de la vacuna contra la COVID-19 y las nuevas normas para medicamentos e ingredientes de bajo riesgo.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","width":800,"height":600,"caption":"Brazil Anvisa Updates Covid 19 Vaccine Strains Low Risk Medicines And Ingredient Rules"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6","name":"Shaffa Renaningtyas"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=9742"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9742\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/9743"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=9742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=9742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=9742"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}